David Tayar

Partner

Paris
Willkie Farr & Gallagher LLP
21-23 rue de la Ville l'Evêque
75008 Paris
T +33 1 53 43 4690
F +33 1 40 06 9606
dtayarwillkie.com

David Tayar is a partner in the Antitrust and Competition Practice Group. He has extensive experience in handling first and second stage complex merger control investigations before both European and French antitrust agencies and in coordinating multijurisdictional filings. He regularly advises clients in restrictive arrangements and monopolization cases before European and French competition authorities and courts.

David advises French and foreign clients in a wide variety of industries, with a special focus on the pharmaceutical, banking and consumer products sectors. He is a member of the board of the Association des Avocats Pratiquant le Droit de la Concurrence (APDC)

Chambers Europe (2015) and numerous other publications (Legal 500, PLC Which Lawyer) rank David among the leading individuals practicing in the area of Competition/European Law in France.

Highlights

David Tayar is a partner in the Antitrust and Competition Practice Group. He has extensive experience in handling first and second stage complex merger control investigations before both European and French antitrust agencies and in coordinating multijurisdictional filings. He regularly advises clients in restrictive arrangements and monopolization cases before European and French competition authorities and courts.

David advises French and foreign clients in a wide variety of industries, with a special focus on the pharmaceutical, banking and consumer products sectors. He is a member of the board of the Association des Avocats Pratiquant le Droit de la Concurrence (APDC)

Chambers Europe (2015) and numerous other publications (Legal 500, PLC Which Lawyer) rank David among the leading individuals practicing in the area of Competition/European Law in France.

Selected Significant Matters

  • Rexel in its acquisition of the assets of SCT Toutelectric.
  • Teva Pharmaceuticals in its $6.8 billion acquisition Cephalon.
  • Teva Pharmaceuticals in two high profile antitrust investigations in relation to patent settlements.
  • Crédit Mutuel in four antitrust investigations in relation to interchange fees.
  • Ingram Micro in an antitrust investigation concerning the distribution of Apple products.
  • Teva Pharmaceuticals in its $5 billion acquisition Ratiopharm GmbH.
  • Teva Pharmaceuticals in its $9 billion merger with Barr Pharmaceuticals.
  • Macquarie Capital and Jarden Corporation in the acquisition of Rossignol, a leading winter sports company.
  • France Télévisions, the leading French public television group in proceedings before the French Competition Council in a restraint of trade and monopolization case related to a "catch up TV" agreement with telecom operator Orange.
  • Total in a private enforcement litigation case against three large chemical companies in relation to a cartel in organic peroxides.
  • Gaz de France in its merger with Suez.
  • Crédit Mutuel in European Court proceedings to obtain the annulment of a Commission decision ordering the reimbursement of more than Euro 160 million of alleged State aid.

Prior Experience

Prior to joining Willkie, David was with Freshfields Bruckhaus Deringer.

Selected Publications and Lectures

  • Co-editor of the State aid section of the prestigious French antitrust journal Revue Lamy de la Concurrence, Quarterly contributions
  • The European settlement procedure: a practitioner’s point of view - Concurrences, April-June 2008
  • Will the Microsoft case bring to an end the outsourcing of remedies monitoring ? (L’arrêt Microsoft marque-t-il la fin de l’externalisation du contrôle des engagements en matière de concentration ?)" - Revue Lamy de la Concurrence, January - March 2008
  • L’autonomie procédurale des États membres à l’épreuve du principe d’effectivité du droit communautaire : la Cour est-elle un arbitre impartial ? - Les Petites Affiches, 4 July 2007
  • Réflexions à propos de l’arrêt Pearle - Les Petites Affiches, 2 December 2005
  • Settlement procedures in Community and French antitrust law - April 2008
  • Antitrust fines: Legal and economic aspects - A point of view with the EC Commission and the French Competition Council - March 2007